Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
Katherine R Tuttle, Sibylle J. Hauske, María Eugênia Fernandes Canziani, Maria Luiza Caramori, David Z.I. Cherney, Lisa Cronin, Hiddo J.L. Heerspink, Christian Hugo, Masaomi Nangaku, Ricardo Correa‐Rotter, Arnold Silva, Shimoli Shah, Zhichao Sun, Dorothea Urbach, Dick de Zeeuw, Peter Rossing, Peter Rossing, Sibylle J. Hauske, María Eugênia Fernandes Canziani, Maria Luiza Caramori, David Z.I. Cherney, Lisa Cronin, Hiddo J.L. Heerspink, Christian Hugo, Masaomi Nangaku, Ricardo Correa‐Rotter, Arnold Silva, Shimoli Shah, Zhichao Sun, Dorothea Urbach, Dick de Zeeuw, Peter Rossing, Cheuk‐Chun Szeto, Diego Echeverri, Edouard Martin, Ming Li Yee, William Wah, Ray Wang, Bobby Chacko, Shriram Swaminathan, Richard J. MacIsaac, Hikaru Hashimura, Glenn M. Ward, Katrien De Vusser, Kathleen Claes, Dirk Kuypers, Björn Meijers, Amaryllis H. Van Craenenbroeck, Robert Hilbrands, Corinne Debroye, Karl Martin Wissing, Michel Jadoul, Nathalie Demoulin, Serge Treille de Grandsaigne, Ishak Beklevic, Diane Marcoux, F Liénart, Claude Daper, V de Brouckère, Mercédès Heureux, João Soares Felício, Karem Miléo Felício, Daniella Leite, Franciane Trindade Cunha de Melo, Natércia Neves Marques de Queiroz, Ana Carolina Souza, Jocyelle Vieira, Roberto Jorge da Silva Franco, Adriana Aparecida Mendes, Giovana Picolli, Luís Henrique Santos Canani, Carla Sartori, Adriana Valenti, Freddy G. Eliaschewitz, Renata Luísa Bona, Denise Reis Franco, Denise Ludovico Costa de Castro, Vanessa Magalhaes, Marcelo G. de Oliveira, Célia Regina Sampaio, Guilherme Visconti, Bruno Halpern, Camila Nihei, Bruna V. Pessoa, Carlos Eduardo Seraphim, Daniel Barbedo Vasconcelos Santos, Cláudia Brito, J. B. Douverny, Marina Colella, Cristina Gazeta, Monique Vercia, Renato Watanabe, Theodora Temelkova, Dimo Kjurkchiev, Silviya Statkova, Iliya Popov, Radosveta Radeva, Lachezar Arabadzhiev, Mariya Binova, Aleksandar Bosilkov